Page 130 - Roche Low Code Enablement Application Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche low code enablement application platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Low Code Enablement Application Platform Today - Breaking & Trending Today

Press Release : New data for Roche's OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis

Message :
Required fields
85% of treatment-naïve, early-stage relapsing-remitting multiple
sclerosis (RRMS) patients achieved no evidence of disease activity (NEDA)
in open-label Phase IIIb ENSEMBLE study
OCREVUS significantly slowed loss of brain tissue within T2 MRI lesions
in primary progressive multiple sclerosis (PPMS) in post-hoc analysis of
Phase III ORATORIO study
OCREVUS-treated patients show highest adherence and persistence rates
compared with other disease-modifying therapies (DMTs) in two-year U.S.
claims analysis
Basel, 16 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today
announced new OCREVUS(R) (ocrelizumab) analyses supporting its
significant benefit on disease progression in early-stage
relapsing-remitting multiple sclerosis (RRMS) and primary progressive MS ....

United States , United Kingdom , Levi Garraway , European Union , American Academy Of Neurology , Head Of Global Product Development , American Academy , Annual Meeting , Chief Medical Officer , Global Product , Disability Status Scale , North America , South America , Middle East , Eastern Europe , World Health , Organization Model Lists , Essential Medicines , Dow Jones , Roche Holding Ag Stock Exchange , Press Release , Tudy Rog Ch0012032048 , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , லெவி க்யாரவ , ஐரோப்பிய தொழிற்சங்கம் ,

F. Hoffmann-La Roche Ltd: FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

? Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment Basel, 13 April 2020 - Roche ....

United States , Nathalie Meetz , Jon Kaspar Bayard , Levi Garraway , Daniel Grotzky , Karl Mahler , Kenneth Mendez , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Loren Kalm , Lisa Tuomi , Patrick Barth , Karsten Kleine , Allergy Foundation Of America , Drug Administration , Genentech Inc , Head Of Global Product Development , Novartis Pharmaceuticals Corporation , Roche Group , Pharmaceuticals Industry , Roche Group Media Relations , Biologics License Application , Chief Medical Officer , Global Product ,

The Irish Times Business Person of the Month: Matt Cooper

The Irish Times Business Person of the Month: Matt Cooper
Inflazome sells to Swiss pharma giant Roche for an initial €380 million
Tue, Apr 13, 2021, 02:06

The spark behind Inflazome came when Australian chemist Matt Cooper met Irish immunologist Luke O’Neill at a medical conference. The two men brainstormed the role of inflammasomes - part of the body’s immune system - in a host of serious chronic diseases when they spiral out of control.
Eight years later - and four years after the two men set up the company in Dublin - Inflazome was sold to Swiss pharma giant Roche for an initial €380 million. ....

Matt Cooper , Luke Oneill , Lukeo Neill , Prof Cooper , Pharma Medtech , Businessperson Awards , மேட் கூப்பர் , லூக் ஓனேிழில் , ப்ரொஃப் கூப்பர் , பார்மா மெதிதேச் ,

remdesivir: Cipla doubles remdesivir production to meet 'unprecedented' demand

"We have scaled up the production of remdesivir by 2x from the last wave of the pandemic," Cipla said in a statement. "Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network." ....

United States , World Health Organization , Cipla Ltd , Covid 19 , Corona Virus , Remdesivir Production , ஒன்றுபட்டது மாநிலங்களில் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சிப்லா லிமிடெட் , கொரோனா வைரஸ் ,

Roche, Biocorp begin French rollout of add-on device connecting insulin pens to smartphone apps

Apr 13, 2021 11:58am
The Mallya device, compatible with most disposable insulin pens, automatically transmits daily insulin data to diabetes patients’ healthcare providers via Roche’s Gluci-Chek app. (Roche)
Need to automatically compile data gathered by an insulin pen and send it to a healthcare provider? There’s a device-connected app for that.
Less than a year after signing their initial distribution agreement, Roche Diabetes Care France has begun making Biocorp’s Mallya device available in pharmacies across France.
The French device maker’s smart sensor connects to most disposable insulin injection pens to collect data about each injection. Mallya automatically transmits that data to Roche’s Gluci-Chek smartphone app over Bluetooth. The dosage, insulin type, date and time information can then be logged and shared with healthcare providers via the Roche Diabetes Care Platform. ....

Roche Gluci Chek , Sanofi Solostar , Biocorp Mallya , Roche Diabetes Care France , Roche Diabetes Care , Medical Device , Injection Pen , ரோச் நீரிழிவு நோய் பராமரிப்பு பிரான்ஸ் , ரோச் நீரிழிவு நோய் பராமரிப்பு , நீரிழிவு நோய் ,